I also believe we will get "something" by EOY. Wh
Post# of 148190
But some positive development / communication, etc. from the conference maybe? Or data published and released on a format that is more robust, and provides more predictive future efficacy?
Basically, we need to bridge the gap between where we are now, and CA's comment that our drug could be "standard of care" for one of these massive indications. It's a massive gap given that we sit at a 300MM market cap, and the market cap would be in the tens of billions if that becomes true - we just need to start connecting the dots such that the investor community starts to buy into that story.